Status:
COMPLETED
Continuous Cellsaver and Neurocognitive Decline Post Cardiac Surgery
Lead Sponsor:
University Health Network, Toronto
Collaborating Sponsors:
Heart and Stroke Foundation of Ontario
Conditions:
Heart Disease
Neurocognitive Decline
Eligibility:
All Genders
60+ years
Phase:
PHASE4
Brief Summary
Patients having cardiac surgery to correct their heart disease may suffer a decline in mental and neurologic abilities. Passage of small particles of fat, tissue waste and air bubbles to the brain whi...
Eligibility Criteria
Inclusion
- Age \> 65 years,
- elective CABG surgery
- signed informed consent
Exclusion
- Severe kidney (creatinine \> 2.5mg/dL and
- liver disease (bilirubin \> 2 mg/dL)
- symptomatic cerebrovascular disease
- alcoholism
- psychiatric illness
- patients who are unable to read or who have less than a 7th grade education.
Key Trial Info
Start Date :
December 1 2001
Trial Type :
INTERVENTIONAL
End Date :
January 1 2007
Estimated Enrollment :
312 Patients enrolled
Trial Details
Trial ID
NCT00296985
Start Date
December 1 2001
End Date
January 1 2007
Last Update
November 27 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Toronto General Hospital, University Health Network
Toronto, Ontario, Canada, M5G 2C4